EUVIMEDEUVIMED entdecken
Systematische Übersicht

Efficacy, Immune Response, and Safety of Dengue Vaccines in Adolescents: A Systematic Review

Ramtin Naderian, Majid Eslami, Sajjad Ahmad, Elham Paraandavaji, Shayan Yaghmayee, Masood Soltanipur, Rayan Naderian, Omid Pajand, Parisa Tajdini, Akram Alizadeh, Samira Sanami iD

Reviews in Medical Virology · 2025

DOI: 10.1002/rmv.70035 ↗

Kurz gefasst

Systematische Übersicht in der Zeitschrift Reviews in Medical Virology, 2025. Verfasst von Ramtin Naderian und 10 weiteren Autor:innen. Beteiligte Einrichtung: Nervous System Stem Cells Research Center, Semnan University of Medical Sciences, Semnan, Iran. Hauptthemen laut MEDLINE: Dengue Vaccines, Dengue, Dengue Virus, Vaccine Efficacy. Die Arbeit wurde bisher 13-mal zitiert (Crossref) und nennt 79 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Both health and economic burdens of dengue virus (DENV), as an increasingly prevalent pathogen and global threat, exist in endemic regions. Vaccination is a key strategy in decreasing dengue morbidity and mortality. This systematic review assesses the efficacy, immune response and safety of dengue vaccines (Qdenga (TAK‐003) and Dengvaxia (CYD‐TDV)) in adolescents against the need for evidence‐based data for dengue vaccination strategies. We performed a systematic search of six databases (Scopus, PubMed, Web of Science, Cochrane, clinical trials. gov, and MEDLINE) for studies published until October 2024. A total of 482 articles were identified, 32 studies met the inclusion criteria after removing duplicates and title and abstract screening. Immunogenicity and safety profiles for both vaccines. TAK‐003 showed high seropositivity rates with all of the four DENV serotypes, especially for DENV‐2, with sustained antibody responses 3 years after vaccination. CYD‐TDV induced neutralising antibodies with balanced activity, but such an immune response was most efficient in individuals with baseline seropositivity, for whom greater efficacy was observed. Most adverse events were mild to moderate, such as transitory pain at the injection site and headache, while serious adverse events were rare and did not correlate with vaccination. Nonetheless, specific issues regarding serotype‐unique efficacy variations and the threat of vaccine‐induced immune enhancement in seronegative groups contribute to worry. These findings highlighted the importance of TAK‐003 and CYD‐TDV in reducing the impact of dengue, especially in endemic regions. Ongoing research is essential to refine vaccine deployment strategies, optimise protection across diverse populations, and address outstanding concerns regarding long‐term immunity and safety in seronegative individuals.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Dengue VaccinesDengueDengue VirusVaccine EfficacyHumansAdolescentAntibodies, ViralAntibodies, NeutralizingVaccinationImmunogenicity, Vaccine

Stichwörter der Autor:innen

CYD‐TDVTAK‐003dengue vaccinesefficacyimmunogenicity

Substanzen

Dengue VaccinesAntibodies, ViralAntibodies, NeutralizingCYD-TDV vaccine

Autor:innen und Institutionen

  • Nervous System Stem Cells Research Center, Semnan University of Medical Sciences, Semnan, Iran.
  • Health Policy Research Center, Institute of Health, Shiraz University of Medical Sciences, Shiraz, Iran.
  • Cancer Research Center, Semnan University of Medical Sciences, Semnan, Iran.
  • Department of Bacteriology and Virology, Semnan University of Medical Sciences, Semnan, Iran.
  • Department of Health and Biological Sciences, Abasyn University, Peshawar, Pakistan.
  • Clinical Research Development Center, Baharloo Hospital, Tehran University of Medical Sciences, Tehran, Iran.

ORCID-Profile: Samira Sanami

Zitieren

APA

Naderian, R., Eslami, M., Ahmad, S., Paraandavaji, E., Yaghmayee, S., Soltanipur, M., Naderian, R., Pajand, O., Tajdini, P., Alizadeh, A., & Sanami, S. (2025). Efficacy, Immune Response, and Safety of Dengue Vaccines in Adolescents: A Systematic Review. Reviews in Medical Virology. https://doi.org/10.1002/rmv.70035

Vancouver

Naderian R, Eslami M, Ahmad S, Paraandavaji E, Yaghmayee S, Soltanipur M, et al. Efficacy, Immune Response, and Safety of Dengue Vaccines in Adolescents: A Systematic Review. Reviews in Medical Virology. 2025. doi:10.1002/rmv.70035

BibTeX
@article{Naderian2025,
  author = {Naderian, Ramtin and Eslami, Majid and Ahmad, Sajjad and Paraandavaji, Elham and Yaghmayee, Shayan and Soltanipur, Masood and Naderian, Rayan and Pajand, Omid and Tajdini, Parisa and Alizadeh, Akram and Sanami, Samira},
  title = {Efficacy, Immune Response, and Safety of Dengue Vaccines in Adolescents: A Systematic Review},
  journal = {Reviews in Medical Virology},
  year = {2025},
  doi = {10.1002/rmv.70035}
}
Kostenlos starten →